ICE, a derivatives exchange and clearing house operator, is making its second bid to buy NYSE in a deal that will give it control of Liffe, Europe’s second-largest derivatives market, and boost its presence in the interest-rate futures business.
It would also strengthen the Atlanta-based company against US rivals CME and Nasdaq OMX, and European competitor Deutsche Boerse.
CE’s EU filing was published on the European Commission website yesterday. The European Commission is the competition regulator for the EU’s 27 member states.
Antitrust lawyers say the deal raises relatively minor competition concerns that could be addressed if ICE were to agree to sell some of its assets.